Rani Therapeutics Holdings, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE4Rani Therapeutics Holdings, Inc.RANISep 29

   2 insider filings

   Talat Imran, insider filing for RANI

   Show all 2

   • 4Insider filing for RANISep 29
   • 4Insider filing for RANISep 29

   Talat Imran, reporting

2. ROUTINESCHEDULE 13G/ARani Therapeutics Holdings, Inc.RANIAug 14

   Ownership stake disclosure by RA CAPITAL MANAGEMENT, L.P. (amended)

   RA CAPITAL MANAGEMENT, L.P., filed by

3. NOTABLE10-QRani Therapeutics Holdings, Inc.RANIAug 13

   Quarterly report

4. ROUTINE8-KRani Therapeutics Holdings, Inc.RANIAug 13

   Current report

5. ROUTINE4Rani Therapeutics Holdings, Inc.RANIAug 4

   2 insider filings

   Michelle Gilson, insider filing for RANI

   Show all 2

   • 4Insider filing for RANIAug 4
   • 3New insider at RANIAug 4

   Michelle Gilson, reporting

6. ROUTINE8-KRani Therapeutics Holdings, Inc.RANIAug 4

   Current report

7. ROUTINESCHEDULE 13G/ARani Therapeutics Holdings, Inc.RANIJul 31

   Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC (amended)

   VANGUARD CAPITAL MANAGEMENT LLC, filed by

8. ROUTINE4Rani Therapeutics Holdings, Inc.RANIJul 23

   Mir A Imran, insider filing for RANI

   Mir A Imran, reporting

9. ROUTINE4Rani Therapeutics Holdings, Inc.RANIJul 21

   3 insider filings

   Alireza Javadi, insider filing for RANI

   Show all 3

   • 4Insider filing for RANIJul 21
   • 4Insider filing for RANIJul 21
   • 4Insider filing for RANIJul 21

   Alireza Javadi, reporting

10. ROUTINE4Rani Therapeutics Holdings, Inc.RANIJul 21

    Nicholas Maestas, insider filing for RANI

    Nicholas Maestas, reporting

11. ROUTINES-8Rani Therapeutics Holdings, Inc.RANIJul 15

    Employee stock plan registration

12. ROUTINE3Rani Therapeutics Holdings, Inc.RANIJul 8

    Nicholas Maestas, new insider at RANI

    Nicholas Maestas, reporting

13. ROUTINE4Rani Therapeutics Holdings, Inc.RANIJun 5

    3 insider filings

    Kate McKinley, insider filing for RANI

    Show all 3

    • 4Insider filing for RANIJun 5
    • 4Insider filing for RANIJun 5
    • 4Insider filing for RANIJun 5

    Kate McKinley, reporting

14. ROUTINE4Rani Therapeutics Holdings, Inc.RANIJun 1

    6 insider filings

    Lisa Ann Rometty, insider filing for RANI

    Show all 6

    • 4Insider filing for RANIJun 1
    • 4Insider filing for RANIJun 1
    • 4Insider filing for RANIJun 1
    • 4Insider filing for RANIJun 1
    • 4Insider filing for RANIJun 1
    • 4Insider filing for RANIJun 1

    Lisa Ann Rometty, reporting

15. NOTABLESCHEDULE 13D/ARani Therapeutics Holdings, Inc.RANIMay 28

    Ownership stake disclosure by Samsara BioCapital, L.P. (amended)

    Samsara BioCapital, L.P., filed by

16. NOTABLE10-QRani Therapeutics Holdings, Inc.RANIMay 15

    Quarterly report

17. ROUTINE8-KRani Therapeutics Holdings, Inc.RANIMay 15

    Current report

18. ROUTINESCHEDULE 13G/ARani Therapeutics Holdings, Inc.RANIMay 15

    Ownership stake disclosure by SymBiosis Capital Partners, LLC (amended)

    SymBiosis Capital Partners, LLC, filed by

19. ROUTINESCHEDULE 13GRani Therapeutics Holdings, Inc.RANIApr 30

    Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC

    VANGUARD CAPITAL MANAGEMENT LLC, filed by

20. ROUTINEARSRani Therapeutics Holdings, Inc.RANIApr 16

    Annual report to shareholders

21. ROUTINEDEFA14ARani Therapeutics Holdings, Inc.RANIApr 16

    Additional proxy materials

22. ROUTINEDEF 14ARani Therapeutics Holdings, Inc.RANIApr 16

    Proxy statement

23. ROUTINE3Rani Therapeutics Holdings, Inc.RANIMar 27

    Alireza Javadi, new insider at RANI

    Alireza Javadi, reporting

24. ROUTINESCHEDULE 13G/ARani Therapeutics Holdings, Inc.RANIMar 27

    Ownership stake disclosure by VANGUARD GROUP INC (amended)

    VANGUARD GROUP INC, filed by

25. ROUTINES-8Rani Therapeutics Holdings, Inc.RANIMar 26

    Employee stock plan registration

26. NOTABLE10-KRani Therapeutics Holdings, Inc.RANIMar 26

    Annual report

27. ROUTINE8-KRani Therapeutics Holdings, Inc.RANIMar 26

    Current report

28. ROUTINESCHEDULE 13GRani Therapeutics Holdings, Inc.RANIFeb 13

    Ownership stake disclosure by AWM Investment Company, Inc.

    AWM Investment Company, Inc., filed by

29. ROUTINESCHEDULE 13GRani Therapeutics Holdings, Inc.RANIFeb 12

    Ownership stake disclosure by SymBiosis Capital Partners, LLC

    SymBiosis Capital Partners, LLC, filed by

30. ROUTINESCHEDULE 13GRani Therapeutics Holdings, Inc.RANIJan 30

    Ownership stake disclosure by VANGUARD GROUP INC

    VANGUARD GROUP INC, filed by

31. ROUTINE8-KRani Therapeutics Holdings, Inc.RANIJan 2

    Current report

32. ROUTINEDEF 14CRani Therapeutics Holdings, Inc.RANIDec 5, 2025

    DEF 14C filing

33. ROUTINEEFFECTRani Therapeutics Holdings, Inc.RANIDec 4, 2025

    Registration declared effective

34. ROUTINE424B5Rani Therapeutics Holdings, Inc.RANIDec 3, 2025

    Securities offering

35. ROUTINEPRE 14CRani Therapeutics Holdings, Inc.RANINov 25, 2025

    PRE 14C filing

36. ROUTINESCHEDULE 13G/ARani Therapeutics Holdings, Inc.RANINov 14, 2025

    Rani Therapeutics Holdings, Inc. (RANI) filed a Schedule 13G/A, disclosing that ARMISTICE CAPITAL, LLC has decreased its beneficial ownership in the company to below 5%.

    ARMISTICE CAPITAL, LLC, filed by

37. ROUTINES-3Rani Therapeutics Holdings, Inc.RANINov 7, 2025

    Securities offering

38. NOTABLE10-QRani Therapeutics Holdings, Inc.RANINov 6, 2025

    Quarterly report

39. ROUTINE8-KRani Therapeutics Holdings, Inc.RANINov 6, 2025

    Current report

Older filings on EDGAR